Dr. Jonathan C. Nachtigall, DO

Dr. Nachtigall practices at Lancaster General Hospital in Lancaster, Pennsylvania, part of University of Pennsylvania.

Dr. Nachtigall's NPI, 1790985786, was assigned on July 19, 2007. Dr. Nachtigall graduated from Philadelphia College of Osteopathic Medicine in 2007. Dr. Nachtigall holds Pennsylvania license OS014516.

Dr. Nachtigall's primary practice is Lancaster General Hospital, at 555 North Duke Street, Lancaster, PA 17602 in Lancaster County. The practice phone is (717) 544-5511.

Dr. Nachtigall's primary practice is Lancaster General Hospital in Lancaster, Pennsylvania, part of University of Pennsylvania. Dr. Nachtigall is also affiliated with Penn State Health Milton S. Hershey Medical Center. The medical group on file is The Heart Group of Lancaster General Health. Dmand AI also links Dr. Nachtigall to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nachtigall practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Nachtigall's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Nachtigall is licensed in Pennsylvania.

CMS data shows 9,865 Medicare services from Dr. Nachtigall across 25 procedure codes in 2024, for 6,587 Medicare patients. Medicare paid $165,870 for them.

CMS counts 6,587 Medicare patients who saw Dr. Nachtigall in 2024. The largest group is 65 to 74, with 2,560 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nachtigall's median patient age at 67, with 52% women.

In 2024, Dr. Nachtigall wrote 711 Medicare Part D claims for 211 patients. 86% of them were for generic drugs. CMS names the drug for 625 of them, across 13 drugs with 11 or more claims each, at $43,162 in total drug cost. In 2023, CMS named 438 claims across 13 drugs.

Dr. Nachtigall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 53 procedures of coronary angioplasty and stenting by Dr. Nachtigall, more than 85% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Nachtigall in 2014. The most frequent topics are Endovascular Procedures, Femoral Artery and Stents. Dr. Nachtigall's most frequent co-authors are Richard Charles Kovach, MD, Ulrich C. Luft, MD and Eric S. Rosen, DO.

CMS Open Payments shows 46 general payments to Dr. Nachtigall from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 53% of the total. Abiomed paid the most, $1,555.

Dr. Nachtigall graduated from Philadelphia College of Osteopathic Medicine in 2007.